PB Logo (1).png
Pardes Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022 16:01 ET | Pardes Biosciences, Inc
CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel...
Asia Breast Cancer Screening Market Report 2022: Market is Expected to Reach $16.5 Billion by 2027 from $10.1 Billion in 2021, Post Recovery from the Pandemic
May 04, 2022 04:13 ET | Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Breast Cancer Screening Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis" report has been...
Global Liquid Biopsy Markets Report 2022-2027 - Lung Cancer Liquid Biopsy & Circulating Tumor DNA is Anticipated to Dominate
April 29, 2022 04:03 ET | Research and Markets
Dublin, April 29, 2022 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has...
Global Sleep Apnea Diagnostics Market Report to 2030 - Opportunity Analysis and Industry Forecasts
April 28, 2022 06:28 ET | Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Sleep Apnea Diagnostics Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
The Global Non-Animal Alternatives Testing Global Market is Expected to Grow to $1.8 billion in 2025 at a CAGR of 10%
April 22, 2022 08:13 ET | Research and Markets
Dublin, April 22, 2022 (GLOBE NEWSWIRE) -- The "Non-Animal Alternatives Testing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
3787276_Codiak_Logo_White_CMYK.jpg
Codiak Presents New Preclinical Data Supporting Development of a Broadly Protective Pan Beta-Coronavirus Vaccine
April 20, 2022 16:40 ET | Codiak BioSciences, Inc.
– Engineered exosome vaccine construct generated durable, comprehensive immunity in vivo – CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a...
Worldwide TCV Vaccines Industry to 2030 - Featuring GlaxoSmithKline, Sanofi and Bharat Biotech Among Others
April 18, 2022 07:33 ET | Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "TCV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report...
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
April 14, 2022 06:45 ET | BioNTech SE
Data from a subanalysis of 30 sera from a Phase 2/3 clinical trial of children 5 through 11 years of age show a 36-fold increase in SARS-CoV-2 Omicron neutralizing titers following a booster (third)...
Pfizer und BioNTech veröffentlichen Daten zu starker Immunantwort nach Auffrischungsimpfung mit dem COVID-19-Impfstoff bei Kindern im Alter von 5 bis 11 Jahren
April 14, 2022 06:45 ET | BioNTech SE
Daten einer Subanalyse mit 30 Seren aus einer klinischen Phase-2/3-Studie mit Kindern im Alter von 5 bis 11 Jahren zeigen einen 36-fachen Anstieg der neutralisierenden Antikörpertiter gegen die...
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of Health
April 08, 2022 09:25 ET | BioNTech SE
MAINZ, Germany, April 8, 2022 — BioNTech SE (Nasdaq: BNTX) today announced that it is one of the companies in Germany to be granted a pandemic preparedness contract by the Federal Republic of Germany....